Exact Mass: 540.2699

KA-5685

C21H40N4O12 (540.2643)

Tetrahydroaldosterone-3-glucuronide

C27H40O11 (540.257)

Tetrahydroaldosterone-3-glucuronide is a natural human metabolite of Tetrahydroaldosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Tetrahydroaldosterone-3-glucuronide is a natural human metabolite of Tetrahydroaldosterone generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

Atorvastatin lactone

C33H33FN2O4 (540.2424)

PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C27H41O9P (540.2488)

PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 4-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C27H41O9P (540.2488)

PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 7-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0)

C27H41O9P (540.2488)

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0), in particular, consists of one chain of one 7-hydroxy-docosahexaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C27H41O9P (540.2488)

PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 14-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0)

C27H41O9P (540.2488)

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0), in particular, consists of one chain of one 14-hydroxy-docosahexaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C27H41O9P (540.2488)

PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 17-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0)

C27H41O9P (540.2488)

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0), in particular, consists of one chain of one 17-hydroxy-docosahexaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C27H41O9P (540.2488)

PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 16,17-epoxy-docosapentaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0)

C27H41O9P (540.2488)

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0), in particular, consists of one chain of one 16,17-epoxy-docosapentaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

(-)-Gypsetin

C32H36N4O4 (540.2736)

Euphoscopin A

C31H40O8 (540.2723)

Euphornin C

C31H40O8 (540.2723)

Caribaeolin

C30H40N2O7 (540.2835)

Isomalyngamide B

C28H45ClN2O6 (540.2966)

IVHD-valtrate

C27H40O11 (540.257)

[6-Acetyloxy-4a-hydroxy-1-(3-methylbutanoyloxy)spiro[1,5,6,7a-tetrahydrocyclopenta[c]pyran-7,2-oxirane]-4-yl]methyl 3-methyl-2-(3-methylbutanoyloxy)butanoate is a natural product found in Valeriana officinalis and Valeriana jatamansi with data available.

Valtrate hydrine B3

C27H40O11 (540.257)

Chaetoglobosin 540

C34H40N2O4 (540.2988)

Chrestfoline C

C37H36N2O2 (540.2777)

Euphornin G

C31H40O8 (540.2723)

Carthamosterone A

C28H44O10 (540.2934)

Phoenistatin

C29H40N4O6 (540.2948)

Euphoscopin J

C31H40O8 (540.2723)

Murrastifoline C

C37H36N2O2 (540.2777)

Isovouacapenol E

C34H36O6 (540.2512)

C27H40O11

C27H40O11 (540.257)

(1R*,2R*,3E,7R*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyldolabella-3,8(17)-dien-2,7,9,16,18-pentol

C28H44O10 (540.2934)

3beta,9alpha-diacetoxy-7beta-benzoyloxy-15beta-hydroxy-14-oxo-2betaH-jatropha-5E,12E-diene|pubescene D

C31H40O8 (540.2723)

CHEMBL4104264

C31H40O8 (540.2723)

9-Acetoxy-gamma-geraniol-1-O-(4,6-diacetyl-3-angelyl)-beta-D-glucopyranoside|9-Acetoxy-gamma-geraniol-1-O-<4,6-diacetyl-3-angelyl>-beta-D-glucopyranoside

C27H40O11 (540.257)

6beta-acetoxy-8,13-epoxy-labd-14-en-11-one-1alpha-O-beta-glucopyranoside|forskoditerpenoside E

C28H44O10 (540.2934)

khayasin

C31H40O8 (540.2723)

C23H36N6O9

C23H36N6O9 (540.2544)

6beta-O-(2,8-dimethyl-<2E,6E>-octadienoyl)-boschnaloside|6beta-O-(2,8-dimethyl-[2E,6E]-octadienoyl)-boschnaloside

C27H40O11 (540.257)

(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-8,9-epoxydolabell-3-en-2,7,16,18-tetrol

C28H44O10 (540.2934)

ptychantin H

C28H44O10 (540.2934)

EM 5519

C28H36N4O7 (540.2584)

TMC-1 D

C30H40N2O7 (540.2835)

(+)-(7S,8S,8R,8R)-4,4-dihydroxy-3,3,3,5-tetramethoxy-4,8-oxy-8,8-sesquineolignan-7-ol

C31H40O8 (540.2723)

A neolignan isolated from the bark of Machilus robusta.

(1S,4S,5S,6R,7R,8S,9S,10S)-15-acetoxy-1,9-dibenzoyloxy-4,6,8-trihydroxy-dihydro-beta-agarofuran

C31H40O8 (540.2723)

granatumin H|methyl rel-(4R,4aR,6aS,7R,8S,10R,11S,12bS)-4-(furan-3-yl)-1,4,4a,5,6,6a,7,8,9,10,11,12b-dodecahydro-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-7,11-methano-2H-cycloocta[3,4]benzo[1,2-c]pyran-8-acetate

C31H40O8 (540.2723)

methyl 3,7,11,12,15,23-hexaoxo-5alpha-lanost-8-en-26-oate

C31H40O8 (540.2723)

flickinflimioside A

C28H44O10 (540.2934)

xylopyrine-H

C32H36N4O4 (540.2736)

(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyl-8,9-epoxydolabell-3-en-2,7,16,18-tetrol

C28H44O10 (540.2934)

6,7-secoeunicellin|klysimplexin P

C28H44O10 (540.2934)

3-oxo-7,8-dihydro-alpha-ionyl tetra-O-acetyl-beta-D-glucopyranoside|blumenol C-O-beta-D-tetraacetylglucopyranoside

C27H40O11 (540.257)

(20S,22S,23S,24S,25S,26S)-5alpha-chloro-12alpha,22-23,26,24,25-triepoxy-6beta,12beta,17beta,26-tetrahydroxyergosta-1-one|jaborosalactol 26

C28H41ClO8 (540.249)

Capreomycin IIA

C19H32N12O7 (540.2517)

(1R*,2R*,3E,7R*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,8(17)-dien-2,7,9,16,18-pentol

C28H44O10 (540.2934)

20-Deoxy,3,5-dibenzoyl-Ingenol|20-deoxyingenol-3,5-dibenzoate

C34H36O6 (540.2512)

C31H40O8

C31H40O8 (540.2723)

Isovaleroxy-hydroxy dihydrovaltrate

C27H40O11 (540.257)

5,14-diacetoxy-3-benzoyloxy-15-hydroxy-9-oxojatropha-6(17),11E-diene|guyonianin E

C31H40O8 (540.2723)

6-oxo-drimenol-3alpha-isovalerate-isofraxidin-ether

C31H40O8 (540.2723)

Thr Pro Pro Val Gln

C24H40N6O8 (540.2907)

His Glu Gln Lys

C22H36N8O8 (540.2656)

C31H40O8_(1R,5R,6R,13R,14R,16S)-6-(3-Furyl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0~2,11~.0~5,10~]heptadec-10-en-14-yl 2-methylpropanoate

C31H40O8 (540.2723)

Ala His Lys Trp

C26H36N8O5 (540.2809)

Ala His Gln Trp

C25H32N8O6 (540.2445)

Ala His Trp Lys

C26H36N8O5 (540.2809)

Ala His Trp Gln

C25H32N8O6 (540.2445)

Ala Lys His Trp

C26H36N8O5 (540.2809)

Ala Lys Trp His

C26H36N8O5 (540.2809)

Ala Gln His Trp

C25H32N8O6 (540.2445)

Ala Gln Trp His

C25H32N8O6 (540.2445)

Ala Trp His Lys

C26H36N8O5 (540.2809)

Ala Trp His Gln

C25H32N8O6 (540.2445)

Ala Trp Lys His

C26H36N8O5 (540.2809)

Ala Trp Gln His

C25H32N8O6 (540.2445)

Cys Lys Lys Tyr

C24H40N6O6S (540.273)

Cys Lys Tyr Lys

C24H40N6O6S (540.273)

Cys Tyr Lys Lys

C24H40N6O6S (540.273)

Asp Phe Phe Ile

C28H36N4O7 (540.2584)

Asp Phe Phe Leu

C28H36N4O7 (540.2584)

Asp Phe Ile Phe

C28H36N4O7 (540.2584)

Asp Phe Leu Phe

C28H36N4O7 (540.2584)

Asp His Asn Arg

C20H32N10O8 (540.2404)

Asp His Arg Asn

C20H32N10O8 (540.2404)

Asp Ile Phe Phe

C28H36N4O7 (540.2584)

Asp Leu Phe Phe

C28H36N4O7 (540.2584)

Asp Asn His Arg

C20H32N10O8 (540.2404)

Glu Phe Phe Val

C28H36N4O7 (540.2584)

Glu Phe Val Phe

C28H36N4O7 (540.2584)

Glu His Lys Gln

C22H36N8O8 (540.2656)

Glu His Gln Lys

C22H36N8O8 (540.2656)

Glu Lys His Gln

C22H36N8O8 (540.2656)

Glu Lys Gln His

C22H36N8O8 (540.2656)

Glu Gln His Lys

C22H36N8O8 (540.2656)

Glu Gln Lys His

C22H36N8O8 (540.2656)

Glu Val Phe Phe

C28H36N4O7 (540.2584)

Phe Asp Phe Ile

C28H36N4O7 (540.2584)

Phe Asp Phe Leu

C28H36N4O7 (540.2584)

Phe Asp Ile Phe

C28H36N4O7 (540.2584)

Phe Asp Leu Phe

C28H36N4O7 (540.2584)

Phe Glu Phe Val

C28H36N4O7 (540.2584)

Phe Glu Val Phe

C28H36N4O7 (540.2584)

Phe Phe Asp Ile

C28H36N4O7 (540.2584)

Phe Phe Asp Leu

C28H36N4O7 (540.2584)

Phe Phe Glu Val

C28H36N4O7 (540.2584)

Phe Phe Ile Asp

C28H36N4O7 (540.2584)

Phe Phe Leu Asp

C28H36N4O7 (540.2584)

Phe Phe Met Pro

C28H36N4O5S (540.2406)

Phe Phe Pro Met

C28H36N4O5S (540.2406)

Phe Phe Val Glu

C28H36N4O7 (540.2584)

Phe His His Thr

C25H32N8O6 (540.2445)

Phe His Thr His

C25H32N8O6 (540.2445)

Phe Ile Asp Phe

C28H36N4O7 (540.2584)

Phe Ile Phe Asp

C28H36N4O7 (540.2584)

Phe Ile Met Met

C25H40N4O5S2 (540.244)

Phe Ile Val Tyr

C29H40N4O6 (540.2948)

Phe Ile Tyr Val

C29H40N4O6 (540.2948)

Phe Leu Asp Phe

C28H36N4O7 (540.2584)

Phe Leu Phe Asp

C28H36N4O7 (540.2584)

Phe Leu Met Met

C25H40N4O5S2 (540.244)

Phe Leu Val Tyr

C29H40N4O6 (540.2948)

Phe Leu Tyr Val

C29H40N4O6 (540.2948)

Phe Met Phe Pro

C28H36N4O5S (540.2406)

Phe Met Ile Met

C25H40N4O5S2 (540.244)

Phe Met Leu Met

C25H40N4O5S2 (540.244)

Phe Met Met Ile

C25H40N4O5S2 (540.244)

Phe Met Met Leu

C25H40N4O5S2 (540.244)

Phe Met Pro Phe

C28H36N4O5S (540.2406)

Phe Pro Phe Met

C28H36N4O5S (540.2406)

Phe Pro Met Phe

C28H36N4O5S (540.2406)

Phe Thr His His

C25H32N8O6 (540.2445)

Phe Val Glu Phe

C28H36N4O7 (540.2584)

Phe Val Phe Glu

C28H36N4O7 (540.2584)

Phe Val Ile Tyr

C29H40N4O6 (540.2948)

Phe Val Leu Tyr

C29H40N4O6 (540.2948)

Phe Val Tyr Ile

C29H40N4O6 (540.2948)

Phe Val Tyr Leu

C29H40N4O6 (540.2948)

Phe Tyr Ile Val

C29H40N4O6 (540.2948)

Phe Tyr Leu Val

C29H40N4O6 (540.2948)

Phe Tyr Val Ile

C29H40N4O6 (540.2948)

Phe Tyr Val Leu

C29H40N4O6 (540.2948)

His Ala Lys Trp

C26H36N8O5 (540.2809)

His Ala Gln Trp

C25H32N8O6 (540.2445)

His Ala Trp Lys

C26H36N8O5 (540.2809)

His Ala Trp Gln

C25H32N8O6 (540.2445)

His Glu Lys Gln

C22H36N8O8 (540.2656)

His Phe His Thr

C25H32N8O6 (540.2445)

His Phe Thr His

C25H32N8O6 (540.2445)

His His Phe Thr

C25H32N8O6 (540.2445)

His His Thr Phe

C25H32N8O6 (540.2445)

His Lys Ala Trp

C26H36N8O5 (540.2809)

His Lys Glu Gln

C22H36N8O8 (540.2656)

His Lys Gln Glu

C22H36N8O8 (540.2656)

His Lys Trp Ala

C26H36N8O5 (540.2809)

His Gln Ala Trp

C25H32N8O6 (540.2445)

His Gln Glu Lys

C22H36N8O8 (540.2656)

His Gln Lys Glu

C22H36N8O8 (540.2656)

His Gln Arg Thr

C21H36N10O7 (540.2768)

His Gln Thr Arg

C21H36N10O7 (540.2768)

His Gln Trp Ala

C25H32N8O6 (540.2445)

His Arg Gln Thr

C21H36N10O7 (540.2768)

His Arg Thr Gln

C21H36N10O7 (540.2768)

His Thr Phe His

C25H32N8O6 (540.2445)

His Thr His Phe

C25H32N8O6 (540.2445)

His Thr Gln Arg

C21H36N10O7 (540.2768)

His Thr Arg Gln

C21H36N10O7 (540.2768)

His Trp Ala Lys

C26H36N8O5 (540.2809)

His Trp Ala Gln

C25H32N8O6 (540.2445)

His Trp Lys Ala

C26H36N8O5 (540.2809)

His Trp Gln Ala

C25H32N8O6 (540.2445)

Ile Asp Phe Phe

C28H36N4O7 (540.2584)

Ile Phe Asp Phe

C28H36N4O7 (540.2584)

Ile Phe Phe Asp

C28H36N4O7 (540.2584)

Ile Phe Met Met

C25H40N4O5S2 (540.244)

Ile Phe Val Tyr

C29H40N4O6 (540.2948)

Ile Phe Tyr Val

C29H40N4O6 (540.2948)

Ile Met Phe Met

C25H40N4O5S2 (540.244)

Ile Met Met Phe

C25H40N4O5S2 (540.244)

Ile Val Phe Tyr

C29H40N4O6 (540.2948)

Ile Val Tyr Phe

C29H40N4O6 (540.2948)

Ile Tyr Phe Val

C29H40N4O6 (540.2948)

Ile Tyr Val Phe

C29H40N4O6 (540.2948)

Lys Ala His Trp

C26H36N8O5 (540.2809)

Lys Ala Trp His

C26H36N8O5 (540.2809)

Lys Cys Lys Tyr

C24H40N6O6S (540.273)

Lys Cys Tyr Lys

C24H40N6O6S (540.273)

Lys Glu His Gln

C22H36N8O8 (540.2656)

Lys Glu Gln His

C22H36N8O8 (540.2656)

Lys His Ala Trp

C26H36N8O5 (540.2809)

Lys His Glu Gln

C22H36N8O8 (540.2656)

Lys His Gln Glu

C22H36N8O8 (540.2656)

Lys His Trp Ala

C26H36N8O5 (540.2809)

Lys Lys Cys Tyr

C24H40N6O6S (540.273)

Lys Lys Tyr Cys

C24H40N6O6S (540.273)

Lys Gln Glu His

C22H36N8O8 (540.2656)

Lys Gln His Glu

C22H36N8O8 (540.2656)

Lys Trp Ala His

C26H36N8O5 (540.2809)

Lys Trp His Ala

C26H36N8O5 (540.2809)

Lys Tyr Cys Lys

C24H40N6O6S (540.273)

Lys Tyr Lys Cys

C24H40N6O6S (540.273)

Leu Asp Phe Phe

C28H36N4O7 (540.2584)

Leu Phe Asp Phe

C28H36N4O7 (540.2584)

Leu Phe Phe Asp

C28H36N4O7 (540.2584)

Leu Phe Met Met

C25H40N4O5S2 (540.244)

Leu Phe Val Tyr

C29H40N4O6 (540.2948)

Leu Phe Tyr Val

C29H40N4O6 (540.2948)

Leu Met Phe Met

C25H40N4O5S2 (540.244)

Leu Met Met Phe

C25H40N4O5S2 (540.244)

Leu Val Phe Tyr

C29H40N4O6 (540.2948)

Leu Val Tyr Phe

C29H40N4O6 (540.2948)

Leu Tyr Phe Val

C29H40N4O6 (540.2948)

Leu Tyr Val Phe

C29H40N4O6 (540.2948)

Met Phe Phe Pro

C28H36N4O5S (540.2406)

Met Phe Ile Met

C25H40N4O5S2 (540.244)

Met Phe Leu Met

C25H40N4O5S2 (540.244)

Met Phe Met Ile

C25H40N4O5S2 (540.244)

Met Phe Met Leu

C25H40N4O5S2 (540.244)

Met Phe Pro Phe

C28H36N4O5S (540.2406)

Met Ile Phe Met

C25H40N4O5S2 (540.244)

Met Ile Met Phe

C25H40N4O5S2 (540.244)

Met Leu Phe Met

C25H40N4O5S2 (540.244)

Met Leu Met Phe

C25H40N4O5S2 (540.244)

Met Met Phe Ile

C25H40N4O5S2 (540.244)

Met Met Phe Leu

C25H40N4O5S2 (540.244)

Met Met Ile Phe

C25H40N4O5S2 (540.244)

Met Met Leu Phe

C25H40N4O5S2 (540.244)

Met Pro Phe Phe

C28H36N4O5S (540.2406)

Pro Phe Phe Met

C28H36N4O5S (540.2406)

Pro Phe Met Phe

C28H36N4O5S (540.2406)

Pro Met Phe Phe

C28H36N4O5S (540.2406)

Pro Val Tyr Tyr

C28H36N4O7 (540.2584)

Pro Tyr Val Tyr

C28H36N4O7 (540.2584)

Pro Tyr Tyr Val

C28H36N4O7 (540.2584)

Gln Ala His Trp

C25H32N8O6 (540.2445)

Gln Ala Trp His

C25H32N8O6 (540.2445)

Gln Glu His Lys

C22H36N8O8 (540.2656)

Gln Glu Lys His

C22H36N8O8 (540.2656)

Gln His Ala Trp

C25H32N8O6 (540.2445)

Gln His Glu Lys

C22H36N8O8 (540.2656)

Gln His Lys Glu

C22H36N8O8 (540.2656)

Gln His Arg Thr

C21H36N10O7 (540.2768)

Gln His Thr Arg

C21H36N10O7 (540.2768)

Gln His Trp Ala

C25H32N8O6 (540.2445)

Gln Lys Glu His

C22H36N8O8 (540.2656)

Gln Lys His Glu

C22H36N8O8 (540.2656)

Gln Arg His Thr

C21H36N10O7 (540.2768)

Gln Arg Thr His

C21H36N10O7 (540.2768)

Gln Thr His Arg

C21H36N10O7 (540.2768)

Gln Thr Arg His

C21H36N10O7 (540.2768)

Gln Trp Ala His

C25H32N8O6 (540.2445)

Gln Trp His Ala

C25H32N8O6 (540.2445)

Arg His Gln Thr

C21H36N10O7 (540.2768)

Arg His Thr Gln

C21H36N10O7 (540.2768)

Arg Gln His Thr

C21H36N10O7 (540.2768)

Arg Gln Thr His

C21H36N10O7 (540.2768)

Arg Thr His Gln

C21H36N10O7 (540.2768)

Arg Thr Gln His

C21H36N10O7 (540.2768)

Thr Phe His His

C25H32N8O6 (540.2445)

Thr His Phe His

C25H32N8O6 (540.2445)

Thr His His Phe

C25H32N8O6 (540.2445)

Thr His Gln Arg

C21H36N10O7 (540.2768)

Thr His Arg Gln

C21H36N10O7 (540.2768)

Thr Gln His Arg

C21H36N10O7 (540.2768)

Thr Gln Arg His

C21H36N10O7 (540.2768)

Thr Arg His Gln

C21H36N10O7 (540.2768)

Thr Arg Gln His

C21H36N10O7 (540.2768)

Val Glu Phe Phe

C28H36N4O7 (540.2584)

Val Phe Glu Phe

C28H36N4O7 (540.2584)

Val Phe Phe Glu

C28H36N4O7 (540.2584)

Val Phe Ile Tyr

C29H40N4O6 (540.2948)

Val Phe Leu Tyr

C29H40N4O6 (540.2948)

Val Phe Tyr Ile

C29H40N4O6 (540.2948)

Val Phe Tyr Leu

C29H40N4O6 (540.2948)

Val Ile Phe Tyr

C29H40N4O6 (540.2948)

Val Ile Tyr Phe

C29H40N4O6 (540.2948)

Val Leu Phe Tyr

C29H40N4O6 (540.2948)

Val Leu Tyr Phe

C29H40N4O6 (540.2948)

Val Pro Tyr Tyr

C28H36N4O7 (540.2584)

Val Tyr Phe Ile

C29H40N4O6 (540.2948)

Val Tyr Phe Leu

C29H40N4O6 (540.2948)

Val Tyr Ile Phe

C29H40N4O6 (540.2948)

Val Tyr Leu Phe

C29H40N4O6 (540.2948)

Val Tyr Pro Tyr

C28H36N4O7 (540.2584)

Val Tyr Tyr Pro

C28H36N4O7 (540.2584)

Trp Ala His Lys

C26H36N8O5 (540.2809)

Trp Ala His Gln

C25H32N8O6 (540.2445)

Trp Ala Lys His

C26H36N8O5 (540.2809)

Trp Ala Gln His

C25H32N8O6 (540.2445)

Trp His Ala Lys

C26H36N8O5 (540.2809)

Trp His Ala Gln

C25H32N8O6 (540.2445)

Trp His Lys Ala

C26H36N8O5 (540.2809)

Trp His Gln Ala

C25H32N8O6 (540.2445)

Trp Lys Ala His

C26H36N8O5 (540.2809)

Trp Lys His Ala

C26H36N8O5 (540.2809)

Trp Gln Ala His

C25H32N8O6 (540.2445)

Trp Gln His Ala

C25H32N8O6 (540.2445)

Tyr Cys Lys Lys

C24H40N6O6S (540.273)

Tyr Phe Ile Val

C29H40N4O6 (540.2948)

Tyr Phe Leu Val

C29H40N4O6 (540.2948)

Tyr Phe Val Ile

C29H40N4O6 (540.2948)

Tyr Phe Val Leu

C29H40N4O6 (540.2948)

Tyr Ile Phe Val

C29H40N4O6 (540.2948)

Tyr Ile Val Phe

C29H40N4O6 (540.2948)

Tyr Lys Cys Lys

C24H40N6O6S (540.273)

Tyr Lys Lys Cys

C24H40N6O6S (540.273)

Tyr Leu Phe Val

C29H40N4O6 (540.2948)

Tyr Leu Val Phe

C29H40N4O6 (540.2948)

Tyr Pro Val Tyr

C28H36N4O7 (540.2584)

Tyr Pro Tyr Val

C28H36N4O7 (540.2584)

Tyr Val Phe Ile

C29H40N4O6 (540.2948)

Tyr Val Phe Leu

C29H40N4O6 (540.2948)

Tyr Val Ile Phe

C29H40N4O6 (540.2948)

Tyr Val Leu Phe

C29H40N4O6 (540.2948)

Tyr Val Pro Tyr

C28H36N4O7 (540.2584)

Tyr Val Tyr Pro

C28H36N4O7 (540.2584)

Tyr Tyr Pro Val

C28H36N4O7 (540.2584)

Tyr Tyr Val Pro

C28H36N4O7 (540.2584)

TPPVQ

C24H40N6O8 (540.2907)

17-α, 21-dihydroxy-11,20-dioxo-5-β-pregnan-3-α-yl-β-d-glucuronide

C27H40O11 (540.257)

(7E)-(3S)-6,19-epidioxy-26,26,26,27,27,27-hexafluoro-9,10-seco-5(10),7-cholestadiene-3,25-diol

C27H38F6O4 (540.2674)

(5Z,7E)-(1S,3R,23S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,23,25-tetrol

C27H38F6O4 (540.2674)

Tetrahydroaldosterone-3-glucuronide

C27H40O11 (540.257)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

TMC-1D

C30H40N2O7 (540.2835)

A polyene antibiotic that is TMC-1A in which the 2,4-dimethyloct-2-enoyl group has been replaced by an (E)-4,6-dimethyldec-2-enoyl group. TMC-1D is an antitumour antibiotic isolated from Streptomyces sp. A-230.

6,19-epidioxy-26,26,26,27,27,27-hexafluoro-25-hydroxy-6,19-dihydrovitamin D3

C27H38O4F6 (540.2674)

(23S)-26,26,26,27,27,27-hexafluoro-1alpha,23,25-trihydroxyvitamin D3

C27H38O4F6 (540.2674)

ST 21:2;O5;GlcA

C27H40O11 (540.257)

2-acetamido-N-[1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide,2,2,2-trifluoroacetic acid

C22H39F3N6O6 (540.2883)

Atorvastatin lactone

C33H33FN2O4 (540.2424)

Atorvastatin lactone is a proagent form of atorvastatin. Atorvastatin is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor[1].

3,4,5,6-TETRAKIS(BENZYLOXY)-1,2-CYCLOHEXANEDIOL

C34H36O6 (540.2512)

2,3,4,6-tetra-o-benzyl-d-galactopyranose

C34H36O6 (540.2512)

2,7-Bis(4-ethylphenyl)-4,9-diphenylpyrido[2,3-g]quinoline

C40H32N2 (540.2565)

2,3,4,6-tetra-o-benzyl-alpha-d-mannopyranose

C34H36O6 (540.2512)

taurohyodeoxycholic acid sodium salt

C26H47NNaO7S+ (540.2971)

2,3,4,6-Tetra-O-benzyl-D-glucopyranose

C34H36O6 (540.2512)

1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE

C34H36O6 (540.2512)

dinonylnaphthalenedisulfonic acid

C28H44O6S2 (540.2579)

9,10-Bis[phenyl(m-tolyl)-amino]anthracene

C40H32N2 (540.2565)

2,3,4,6-Tetrakis-O-(phenylmethyl)-L-mannose

C34H36O6 (540.2512)

(2S,3R,4S,5S,6R)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol

C34H36O6 (540.2512)

Ponatinib-d8

C29H19D8F3N6O (540.2701)

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester

C31H36N6O3 (540.2849)

hydroxypivalyl hydroxypivalate

C28H44O10 (540.2934)

Desfluoroatorvastatin

C33H36N2O5 (540.2624)

Forskoditerpenoside E

C28H44O10 (540.2934)

A diterpene glycoside that is labd-14-en-11-one substituted by beta-acetoxy group at position 6, an epoxy group between positions 8 and 13 and a beta-D-glucopyranosyloxy group at position 1 (the 1alpha stereoisomer). Isolated from the whole plant of Coleus forskohlii, it shows relaxative effects on isolated guinea pig tracheal spirals in vitro.

26,26,26,27,27,27-hexafluoro-1alpha,23(S),25-trihydroxyvitamin D3

C27H38F6O4 (540.2674)

(2S)-2-amino-N-[[(2S,10R,12S)-12,19-dihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methyl]propanamide

C28H36N4O7 (540.2584)

PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C27H41O9P (540.2488)

PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C27H41O9P (540.2488)

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0)

C27H41O9P (540.2488)

PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C27H41O9P (540.2488)

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0)

C27H41O9P (540.2488)

PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C27H41O9P (540.2488)

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0)

C27H41O9P (540.2488)

PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C27H41O9P (540.2488)

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0)

C27H41O9P (540.2488)

Malyngamide B

C28H45ClN2O6 (540.2966)

A natural product found in Lyngbya majuscula.

Klymollin H

C27H40O11 (540.257)

An eunicellin diterpenoid isolated from the soft coral Klyxum molle.

S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate

C23H45N2O8PS (540.2634)

(+)-(7S,8S,8R,8S)-4,4-dihydroxy-3,3,3,5-tetramethoxy-4,8-oxy-8,8-sesquineolignan-7-ol

C31H40O8 (540.2723)

A neolignan isolated from the barks of Machilus robusta.

8-[1-[4-(Dimethylamino)phenyl]-3-(3-methyl-1-piperidinyl)propyl]-5,7-dimethoxy-4-phenyl-1-benzopyran-2-one

C34H40N2O4 (540.2988)

1-(2-Methoxyphenyl)-3-[4-[[4-[(2-methoxyphenyl)carbamothioylamino]cyclohexyl]methyl]cyclohexyl]thiourea

C29H40N4O2S2 (540.2593)

Heptacyclo[31.3.1.1(3,7).1(9,13).1(15,19).1(21,25).1(27,31)]dotetraconta-1(37),3(42),4,6,9(41),10,12,15(40),16,18,21(39),22,24,27(38),28,30,33,35-octadecaene

C42H36 (540.2817)

N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736)

N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736)

N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736)

1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.2948)

1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.2948)

1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.2948)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C25H40N4O7S (540.2618)

1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.2948)

N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736)

N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736)

(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H36N4O5S (540.2406)

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[(4-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-2-pyridin-4-ylethanone

C32H36N4O4 (540.2736)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C25H40N4O7S (540.2618)

1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.2948)

1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.2948)

1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.2948)

N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736)

N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736)

(1S)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H36N4O5S (540.2406)

Nintedanib(1+)

C31H34N5O4+ (540.2611)

4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-alpha-D-Manp2Me-(1->2)-4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-alpha-D-ManpOMe

C22H40N2O13 (540.253)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C28H44O10 (540.2934)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C28H45O8P (540.2852)

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C28H45O8P (540.2852)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C28H45O8P (540.2852)

Saccharocin

C21H40N4O12 (540.2643)

S-dodecanoyl-4-phosphopantetheine

C23H45N2O8PS (540.2634)

An S-acyl-4-phosphopantetheine obtained by formal condensation of the thiol group of D-pantetheine 4-phosphate with the carboxy group of dodecanoic acid.

methyl 4,6-dideoxy-4-(3-deoxy-D-glycero-tetronamido)-alpha-D-Manp2Me-(1->2)-4,6-dideoxy-4-(3-deoxy-D-glycero-tetronamido)-alpha-D-Manp

C22H40N2O13 (540.253)

An amido disaccharide corresponding to the (2R)-2,4-dihydroxybutanoyl diastereomer of the fragment which mimicks the terminus of the O-polysaccharide of Vibrio cholerae O:1, serotype Ogawa.

SQMG 15:1

C24H44O11S (540.2604)

MGGA 19:4

C28H44O10 (540.2934)

PA O-25:6;O

C28H45O8P (540.2852)

PA P-18:1/7:4;O

C28H45O8P (540.2852)

PA 18:4/6:2;O

C27H41O9P (540.2488)

PA 20:5/4:1;O

C27H41O9P (540.2488)

PA 24:6;O

C27H41O9P (540.2488)

LPG 18:2;O2

C24H45O11P (540.2699)

PG 14:0/4:1;O

C24H45O11P (540.2699)

PG 18:1;O

C24H45O11P (540.2699)

PEth 22:6;O

C27H41O9P (540.2488)

PEth 23:5

C28H45O8P (540.2852)

PM 23:6;O

C27H41O9P (540.2488)

PM 24:5

C28H45O8P (540.2852)

ST 22:1;O4;GlcA

C28H44O10 (540.2934)

ST 25:6;O2;GlcA

C31H40O8 (540.2723)

ST 21:3;O6;Hex

C27H40O11 (540.257)

ST 22:2;O5;Hex

C28H44O10 (540.2934)

ST 25:7;O3;Hex

C31H40O8 (540.2723)

ST 28:3;O5;S

C28H44O8S (540.2757)

(3s)-5-{[(1r,3as,4s,9r,11r,12as)-1-[2-(acetyloxy)propan-2-yl]-4,9,11-trihydroxy-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(3s)-5-{[(1r,3as,4s,9r,11r,12as)-4-(acetyloxy)-9,11-dihydroxy-1-(2-hydroxypropan-2-yl)-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(1s,2r,3ar,4r,5r,11r,13as)-3a,4-bis(acetyloxy)-11-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(1s,2r,3ar,4r,5s,11r,13as)-3a,4-bis(acetyloxy)-11-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

1-methoxy-3-methyl-9-{[(3r)-3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazol-5-yl]methyl}carbazole

C37H36N2O2 (540.2777)

2-{[(2s,3r)-2-{[(2r)-2-[(2s)-2-amino-n,4-dimethylpentanamido]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-3-hydroxybenzoic acid

C29H40N4O6 (540.2948)

(1r,2r,3as,4s,5r,11r,13as)-3a,11-bis(acetyloxy)-4-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

5-{[11-(acetyloxy)-6-hydroxy-15-(2-hydroxypropan-2-yl)-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

5-{[4-(acetyloxy)-9,11-dihydroxy-1-(2-hydroxypropan-2-yl)-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(3s)-5-{[(1s,3r,5r,6r,9z,11s,12s,15r)-11-(acetyloxy)-6-hydroxy-15-(2-hydroxypropan-2-yl)-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(4r,4as,5r,6ar,11as,11br)-4-[(benzoyloxy)methyl]-4a-hydroxy-4,11b-dimethyl-7-methylidene-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl benzoate

C34H36O6 (540.2512)

4,9-bis(acetyloxy)-3a-hydroxy-2,5,8,8,12-pentamethyl-11-oxo-1h,2h,3h,4h,5h,9h,10h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(1s,2s,3ar,4s,5s,11r,13as)-4,11-bis(acetyloxy)-3a-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

5-({1-[2-(acetyloxy)propan-2-yl]-4,9,11-trihydroxy-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl}methoxy)-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(2s,3s,3as,6r,8r,13ar)-3,8-bis(acetyloxy)-13a-hydroxy-2,5,9,9,12-pentamethyl-13-oxo-1h,2h,3h,3ah,6h,7h,8h,10h-cyclopenta[12]annulen-6-yl benzoate

C31H40O8 (540.2723)

6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-14-yl butanoate

C31H40O8 (540.2723)

1-methoxy-3-methyl-9-{[3-methyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazol-5-yl]methyl}carbazole

C37H36N2O2 (540.2777)

3-{[(3r)-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)pyrano[3,2-a]carbazol-11-yl]methyl}-1-methoxy-9h-carbazole

C37H36N2O2 (540.2777)

5-({15-[2-(acetyloxy)propan-2-yl]-6,11-dihydroxy-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl}methoxy)-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(1r,2s,4s,5r,8s,9s,10z,12s)-11-[(acetyloxy)methyl]-5-hydroxy-8-isopropyl-12-methoxy-1,5-dimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-6,10,13-trien-2-yl (2e)-3-(1-methylimidazol-4-yl)prop-2-enoate

C30H40N2O7 (540.2835)

(1r,4s,12r,14s,17r,25s)-12,25-dihydroxy-4,17-bis(2-methylbut-3-en-2-yl)-3,5,16,18-tetraazaheptacyclo[14.10.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0¹⁷,²⁵.0¹⁹,²⁴]hexacosa-6,8,10,19,21,23-hexaene-2,15-dione

C32H36N4O4 (540.2736)

(1s,4r,12s,14s,17s,25r)-12,25-dihydroxy-4,17-bis(2-methylbut-3-en-2-yl)-3,5,16,18-tetraazaheptacyclo[14.10.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0¹⁷,²⁵.0¹⁹,²⁴]hexacosa-6,8,10,19,21,23-hexaene-2,15-dione

C32H36N4O4 (540.2736)

(1s,2s,3ar,4s,5s,9r,13as)-4,9-bis(acetyloxy)-3a-hydroxy-2,5,8,8,12-pentamethyl-11-oxo-1h,2h,3h,4h,5h,9h,10h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

4-[(2s,3r)-4-(4-{[(1s,2r)-1-hydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol

C31H40O8 (540.2723)

2-[(1r,2r,3r,4s,4as,5s,5's,6r,8as)-4,6-bis(acetyloxy)-5-[(acetyloxy)methyl]-3-hydroxy-2,5,5',8a-tetramethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxolan]-5'-yl]ethyl acetate

C28H44O10 (540.2934)

methyl (2r,5r,6r)-6-[(1s,3as,5as,7r,8s,9ar,9br,11ar)-3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,5,6-trihydroxy-2-methylheptanoate

C28H44O10 (540.2934)

(4ar,7r,7as)-6-(acetyloxy)-4a-hydroxy-1-[(3-methylbutanoyl)oxy]-1,5,6,7a-tetrahydrospiro[cyclopenta[c]pyran-7,2'-oxiran]-4-ylmethyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

C27H40O11 (540.257)

3-ethenyl-3,4a,7,7,10a-pentamethyl-1-oxo-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydronaphtho[2,1-b]pyran-6-yl acetate

C28H44O10 (540.2934)

(1s,2r,3ar,4r,5r,11r,13as)-3a,11-bis(acetyloxy)-4-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(3r)-5-{[(1s,3r,5r,6r,9z,11r,12s,15r)-11-(acetyloxy)-6-hydroxy-15-(2-hydroxypropan-2-yl)-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

2-amino-n-({12,19-dihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15,17,19-pentaen-10-yl}methyl)propanimidic acid

C28H36N4O7 (540.2584)

6-hydroxy-9-{6-hydroxy-4-isopropyl-3-oxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-9-yl}-4-methyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C30H32N6O4 (540.2485)

(3s)-5-{[(1r,3as,4r,9r,11r,12as)-4-(acetyloxy)-9,11-dihydroxy-1-(2-hydroxypropan-2-yl)-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(1s,4r,7r,9s)-6-hydroxy-9-[(1r,4s,7s)-6-hydroxy-4-methyl-3-oxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-9-yl]-4-isopropyl-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C30H32N6O4 (540.2485)

(1s,4as,5r,7r,7ar)-5-{[(3e,7e)-9-hydroxy-3,7-dimethyl-2-oxonona-3,7-dien-1-yl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carbaldehyde

C27H40O11 (540.257)

n-(3,4-dihydroxy-3-{6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl)-4,6-dimethyldec-2-enimidic acid

C30H40N2O7 (540.2835)

(1r,2r,3as,4s,5r,11s,13as)-3a,4-bis(acetyloxy)-11-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(1r,2s,5r,6r,13s,14r,16s)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-14-yl butanoate

C31H40O8 (540.2723)

(2s)-2-[(2e,6e,10r)-10,11-dihydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]-4,6,9-trihydroxy-2-methoxy-5,7-dimethylphenalene-1,3-dione

C31H40O8 (540.2723)

methyl 6-{3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2,5,6-trihydroxy-2-methylheptanoate

C28H44O10 (540.2934)

4-[(benzoyloxy)methyl]-4a-hydroxy-4,11b-dimethyl-7-methylidene-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl benzoate

C34H36O6 (540.2512)

4-[(2s,3r)-4-(4-{[(1s,2s)-1-hydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)-2,3-dimethylbutyl]-2-methoxyphenol

C31H40O8 (540.2723)

5-{[(6,8-dimethoxy-2-oxochromen-7-yl)oxy]methyl}-1,1,4a,6-tetramethyl-8-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl 3-methylbutanoate

C31H40O8 (540.2723)

(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a-hydroxy-1-[(3-methylbutanoyl)oxy]-1,5,6,7a-tetrahydrospiro[cyclopenta[c]pyran-7,2'-oxiran]-4-ylmethyl (2r)-3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

C27H40O11 (540.257)

(2r,3s,3as,6r,8r,13ar)-3,8-bis(acetyloxy)-13a-hydroxy-2,5,9,9,12-pentamethyl-13-oxo-1h,2h,3h,3ah,6h,7h,8h,10h-cyclopenta[12]annulen-6-yl benzoate

C31H40O8 (540.2723)

(1s,2s,4r,5r,8s,9s,10z,12r)-11-[(acetyloxy)methyl]-5-hydroxy-8-isopropyl-12-methoxy-1,5-dimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-6,10,13-trien-2-yl (2e)-3-(1-methylimidazol-4-yl)prop-2-enoate

C30H40N2O7 (540.2835)

12,25-dihydroxy-4,17-bis(2-methylbut-3-en-2-yl)-3,5,16,18-tetraazaheptacyclo[14.10.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0¹⁷,²⁵.0¹⁹,²⁴]hexacosa-6,8,10,19,21,23-hexaene-2,15-dione

C32H36N4O4 (540.2736)

(1s,4ar,6s,7r,7as)-6-(acetyloxy)-4a-hydroxy-1-[(3-methylbutanoyl)oxy]-1,5,6,7a-tetrahydrospiro[cyclopenta[c]pyran-7,2'-oxiran]-4-ylmethyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

C27H40O11 (540.257)

(1r,2r,3ar,4s,5s,9s,13ar)-4,9-bis(acetyloxy)-3a-hydroxy-2,5,8,8,12-pentamethyl-11-oxo-1h,2h,3h,4h,5h,9h,10h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

9-benzyl-6-ethyl-1,4,7-trihydroxy-6-methyl-3-[6-(oxiran-2-yl)-6-oxohexyl]-3h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C29H40N4O6 (540.2948)

(1s,2s,3ar,4r,5r,13r,13ar)-4,13-bis(acetyloxy)-3a-hydroxy-2,5,8,8-tetramethyl-12-methylidene-9-oxo-1h,2h,3h,4h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

11-[(2e)-4-[(3s,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-2-en-2-yl]-6,9-dihydroxy-10,11-dihydro-5-oxatetraphen-12-one

C35H40O5 (540.2876)

(4e,7s)-n-[(2z,4z)-2-(chloromethylidene)-6-[(4r)-4-hydroxy-2-oxopyrrolidin-1-yl]-4-methoxy-6-oxohex-4-en-1-yl]-7-methoxy-n-methyltetradec-4-enamide

C28H45ClN2O6 (540.2966)

6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-14-yl 2-methylpropanoate

C31H40O8 (540.2723)

6-(acetyloxy)-4a-hydroxy-1-[(3-methylbutanoyl)oxy]-1,5,6,7a-tetrahydrospiro[cyclopenta[c]pyran-7,2'-oxiran]-4-ylmethyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate

C27H40O11 (540.257)

(2s)-2-amino-n-{[(1s,2s,10r,13r)-12,19-dihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15,17,19-pentaen-10-yl]methyl}propanimidic acid

C28H36N4O7 (540.2584)

(3s)-5-{[(1r,3s,5s,6s,9z,11r,12r,15s)-15-[2-(acetyloxy)propan-2-yl]-6,11-dihydroxy-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

4,11-bis(acetyloxy)-3a-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(1r,2r,5s,6s,13s,14s,16r)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-10-en-14-yl 2-methylpropanoate

C31H40O8 (540.2723)

1-[2,4-bis(acetyloxy)-8a-[(acetyloxy)methyl]-6-hydroxy-2,5,5-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

C28H44O10 (540.2934)

(2e,4z,6e,8e)-12-{[(3r,4ar,8s,10s,10as,10br)-3-hydroxy-4a,8,10b-trimethyl-1-oxo-2h,3h,8h,9h,10h,10ah-naphtho[2,1-b]pyran-10-yl]oxy}-10-hydroxy-5,9,11-trimethyl-12-oxododeca-2,4,6,8-tetraenoic acid

C31H40O8 (540.2723)

4-[(acetyloxy)methyl]-7-hydroxy-6-[(3-methylbutanoyl)oxy]-7-{[(3-methylbutanoyl)oxy]methyl}-1h,6h,7ah-cyclopenta[c]pyran-1-yl 3-hydroxy-3-methylbutanoate

C27H40O11 (540.257)

3,8-bis(acetyloxy)-13a-hydroxy-2,5,9,9,12-pentamethyl-13-oxo-1h,2h,3h,3ah,6h,7h,8h,10h-cyclopenta[12]annulen-6-yl benzoate

C31H40O8 (540.2723)

3a,11-bis(acetyloxy)-4-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(1r,2r,3s,4s,4as,5r,8r,8ar)-4-[(2s,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-5-(acetyloxy)-8-formyl-1-hydroxy-3,4,8a-trimethyl-octahydronaphthalen-2-yl (2e)-3-phenylprop-2-enoate

C31H40O8 (540.2723)

(2r,4ar,5r,8ar)-5-{[(6,8-dimethoxy-2-oxochromen-7-yl)oxy]methyl}-1,1,4a,6-tetramethyl-8-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl 3-methylbutanoate

C31H40O8 (540.2723)

(1s,6s,7r,7as)-4-[(acetyloxy)methyl]-7-hydroxy-6-[(3-methylbutanoyl)oxy]-7-{[(3-methylbutanoyl)oxy]methyl}-1h,6h,7ah-cyclopenta[c]pyran-1-yl 3-hydroxy-3-methylbutanoate

C27H40O11 (540.257)

(2r,3s)-1-[(1r,2r,4r,4ar,6r,8ar)-2,4-bis(acetyloxy)-8a-[(acetyloxy)methyl]-6-hydroxy-2,5,5-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

C28H44O10 (540.2934)

(2e)-n-[(3s,4r)-3,4-dihydroxy-3-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-6-oxocyclohex-1-en-1-yl]-4,6-dimethyldec-2-enimidic acid

C30H40N2O7 (540.2835)

2-[(2-{[2-(2-amino-n,4-dimethylpentanamido)-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylpentylidene)amino]-3-hydroxybenzoic acid

C29H40N4O6 (540.2948)

n-[2-(chloromethylidene)-6-(4-hydroxy-2-oxopyrrolidin-1-yl)-4-methoxy-6-oxohex-4-en-1-yl]-7-methoxy-n-methyltetradec-4-enamide

C28H45ClN2O6 (540.2966)

5-(acetyloxy)-8-formyl-4-{hexahydrofuro[2,3-b]furan-2-yl}-1-hydroxy-3,4,8a-trimethyl-octahydronaphthalen-2-yl 3-phenylprop-2-enoate

C31H40O8 (540.2723)

(4e,7s)-n-[(2z,4e)-2-(chloromethylidene)-6-[(4r)-4-hydroxy-2-oxopyrrolidin-1-yl]-4-methoxy-6-oxohex-4-en-1-yl]-7-methoxy-n-methyltetradec-4-enamide

C28H45ClN2O6 (540.2966)

(1s,2r,3ar,4r,5r,11r,13as)-4,11-bis(acetyloxy)-3a-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(3s)-5-{[(1s,3r,5r,6r,9e,11s,12s,15r)-15-[2-(acetyloxy)propan-2-yl]-6,11-dihydroxy-5,12-dimethyl-4-oxatricyclo[10.3.0.0³,⁵]pentadec-9-en-9-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(2s)-2-amino-n-{[(1s,2s,10r,12s,13r)-12,19-dihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methyl}propanimidic acid

C28H36N4O7 (540.2584)

4-(acetyloxy)-6-{[(2e,6z,10e)-1,12-dihydroxy-2,8,10-trimethyldodeca-2,6,10-trien-6-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-2-methylbut-2-enoate

C28H44O10 (540.2934)

(1r,2r,3ar,4s,5s,11s,13as)-4,11-bis(acetyloxy)-3a-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(2r,3r,4r,5r,6r)-3-(acetyloxy)-6-{[(6z)-8-(acetyloxy)-7-methyl-3-methylideneoct-6-en-1-yl]oxy}-2-[(acetyloxy)methyl]-5-hydroxyoxan-4-yl (2z)-2-methylbut-2-enoate

C27H40O11 (540.257)

3-{[3,5-dimethyl-3-(4-methylpent-3-en-1-yl)pyrano[3,2-a]carbazol-11-yl]methyl}-1-methoxy-9h-carbazole

C37H36N2O2 (540.2777)

(3r,6r,9s,14ar)-9-benzyl-6-ethyl-1,4,7-trihydroxy-6-methyl-3-{6-[(2s)-oxiran-2-yl]-6-oxohexyl}-3h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C29H40N4O6 (540.2948)

11-{4-[(3s,8as)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-2-en-2-yl}-6,9-dihydroxy-10,11-dihydro-5-oxatetraphen-12-one

C35H40O5 (540.2876)

5-[(9-hydroxy-3,7-dimethyl-2-oxonona-3,7-dien-1-yl)oxy]-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carbaldehyde

C27H40O11 (540.257)

(1s,2s,3ar,4r,5s,11r,13as)-3a,4-bis(acetyloxy)-11-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

3a,4-bis(acetyloxy)-11-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

4,13-bis(acetyloxy)-3a-hydroxy-2,5,8,8-tetramethyl-12-methylidene-9-oxo-1h,2h,3h,4h,5h,10h,11h,13h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

3-(acetyloxy)-6-{[8-(acetyloxy)-7-methyl-3-methylideneoct-6-en-1-yl]oxy}-2-[(acetyloxy)methyl]-5-hydroxyoxan-4-yl 2-methylbut-2-enoate

C27H40O11 (540.257)

(3r)-5-{[(1r,3as,4s,9s,11r,12as)-1-[2-(acetyloxy)propan-2-yl]-4,9,11-trihydroxy-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-6-yl]methoxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H44O10 (540.2934)

(1s,2s,3ar,4r,5r,11r,13as)-3a,4-bis(acetyloxy)-11-hydroxy-2,5,8,8,12-pentamethyl-9-oxo-1h,2h,3h,4h,5h,10h,11h,13ah-cyclopenta[12]annulen-1-yl benzoate

C31H40O8 (540.2723)

(3s,3ar,4s,6as,10s,13r,17ar)-4-ethyl-1,13-dihydroxy-3-[(1r)-1-(1h-indol-3-yl)ethyl]-5,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,13h-cyclotrideca[d]isoindole-14,17-dione

C34H40N2O4 (540.2988)

(2e,4e,6e,8e)-12-{[(3r,4as,8r,10s,10as,10br)-3-hydroxy-4a,8,10b-trimethyl-1-oxo-2h,3h,8h,9h,10h,10ah-naphtho[2,1-b]pyran-10-yl]oxy}-10-hydroxy-5,9,11-trimethyl-12-oxododeca-2,4,6,8-tetraenoic acid

C31H40O8 (540.2723)

methyl (2s,5r,6r)-6-[(1s,3as,5as,7r,8s,9ar,9br,11ar)-3a,5a,7,8-tetrahydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,5,6-trihydroxy-2-methylheptanoate

C28H44O10 (540.2934)